Bhutan vs Qatar: Tuberculosis patients living with HIV receiving antiretroviral therapy
Bhutan
3 patients
in 2021
Qatar
3 patients
in 2021
Bhutan rank
117th
Qatar rank
117th
Tuberculosis patients living with HIV receiving antiretroviral therapy over time
- Bhutan
- Qatar
How they compare
Bhutan currently reports 3 patients against 3 patients in Qatar, a difference of 0 patients.
The two have swapped places 6 times across 17 shared years of data; in 2003 it was Qatar ahead.
Bhutan ranks 117th and Qatar ranks 117th of 183 countries.
Bhutan has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Bhutan | Qatar | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 1 patients | 0.2857 patients | 0.7143 patients | Bhutan |
| 2010s | 3.38 patients | 0.375 patients | 3 patients | Bhutan |
| 2020s | 4.5 patients | 2.5 patients | 2 patients | Bhutan |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher tuberculosis patients living with hiv receiving antiretroviral therapy, Bhutan or Qatar?
- Bhutan, at 3 patients against 3 patients in Qatar as of 2021.
- What is the difference in tuberculosis patients living with hiv receiving antiretroviral therapy between Bhutan and Qatar?
- 0 patients, with Bhutan ahead.
- How many years of comparable data are there for Bhutan and Qatar?
- 17 years are reported by both, from 2003 to 2021.
- How do Bhutan and Qatar rank globally for tuberculosis patients living with hiv receiving antiretroviral therapy?
- Bhutan ranks 117th and Qatar ranks 117th of 183 countries.
- Where does this data come from?
- Joint United Nations Programme on HIV/AIDS (2026); Population based on various sources (2024) – with minor processing by Our World in Data, published as Tuberculosis patients living with HIV receiving antiretroviral therapy. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of tuberculosis patients who are living with HIV and receiving antiretroviral therapy.